![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 15, 2010 11:07:52 AM
If InoLife captures JUST 5% of the existing market share for TESTING METABOLIC RATE BECAUSE OF THE NEW FDA BLACK BOX WARNING and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:
$5.56
That's EBITDA, etc. But also without a multiple.
Lop off 40% for margin of error, and it's $3.34
Imagine if 50% market share, or 80%
legend:
5%Mkt share * 9M new Plavix users 3 months = 450,000
5%Mkt share * 48M Plavix users = 2.4M
128 OS
$250 cost
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM